Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 7;85(15):2824-2838.e8.
doi: 10.1016/j.molcel.2025.07.003. Epub 2025 Jul 31.

PALB2 and 53BP1 govern post-resection homologous recombination DNA repair

Affiliations

PALB2 and 53BP1 govern post-resection homologous recombination DNA repair

Yifan Wang et al. Mol Cell. .

Abstract

Homologous recombination (HR) requires the resection of DNA breaks and RAD51 filament formation. Protein complexes that control end resection have been characterized, but regulators of RAD51 loading are not well defined. PALB2 is a mediator of BRCA2-RAD51 DNA break localization; it can also bind BRCA1 or form homodimers with DNA-binding activity via its coiled-coil (CC) domain. Here, we created a CC-mutated mouse allele (Palb2CC) that disrupts CC-mediated interactions. While Palb2CC/CC embryos were not viable, remarkably, intercrossing with mice lacking 53BP1, an inhibitor of PALB2-chromatin contacts, produced live births. However, Palb2CC/CC53bp1-/- mice were tumor prone, and cells had limited RAD51 foci. HR remained inefficient because the CC domain was required for PALB2 to bind to single-stranded (ss)DNA overhangs and subsequently promote PALB2 and RAD51 accumulation. These findings underscore the role of ssDNA binding in localizing PALB2 to DNA breaks while establishing genetic interactions that control the post-end resection steps of mammalian HR.

Keywords: 53BP1; BRCA1; BRCA2; DNA end resection; DNA repair; PALB2; RAD51; coiled-coil; double-stranded DNA break; homologous recombination.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests All authors declare no competing interests.

Similar articles

References

    1. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, and Livingston DM (2006). Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22, 719–729. 10.1016/j.molcel.2006.05.022. - DOI - PubMed
    1. Erkko H, Xia B, Nikkila J, Schleutker J, Syrjakoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen SM, Rapakko K, et al. (2007). A recurrent mutation in PALB2 in Finnish cancer families. Nature 446, 316–319. 10.1038/nature05609. - DOI - PubMed
    1. Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, et al. (2007). Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9, R83. 10.1186/bcr1828. - DOI - PMC - PubMed
    1. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, et al. (2007). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39, 165–167. 10.1038/ng1959. - DOI - PMC - PubMed
    1. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, et al. (2007). Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39, 162–164. 10.1038/ng1947. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources